Spanish Red Biotech Pipeline

Amgen

sotorasib

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Respiratory and Pulmonary system
Indication: Previously treated, locally advanced and unresectable or metastatic non-small cell lung cancer (NSCLC) with the p.G12C mutation in KRAS
Phase: 3Phase III in Spain, 2Phase II in Spain, 1Phase I in Spain